Lunch and Learn: What the M&A, IPOs Trends Tell Us about the Outlook for Innovation in Oncology

Lunch and Learn: Oncology Trends
In a year in which the number of healthcare IPOs tripled, public market enthusiasm has helped stabilize venture investment and fundraising overall. It also led to increased valuations of big exit mergers and acquisitions. Venture investment in healthcare saw the biggest returns since SVB started tracking the data in 2005. Oncology exits were a big reason for the upswing.

In addition to discussing trends in Biotech M&A and IPOs, we will look at the distinctions in oncology versus other indications. Are companies being rewarded by raising more money for phase 2 instead of transacting after stage 1 data? And where do these trends show capital moving ? Using this data, we will talk fundraising strategies, looking at:

  • Which firms are making new investments in the sector
  • Corporate venture capital’s role in healthcare



Lunch and Learn: What the M&A, IPOs Trends Tell Us about the Outlook for Innovation in Oncology


Tuesday, September 16, 2014
11:00AM – 1:00PM


HCP/BayBio Event Center
250 E. Grand Avenue, Suite 26
South San Francisco, CA 94080


Members: Complimentary
Non-Members: $75

  • Early registration is highly advised as space is limited and there will be no on-site registration
  • Late arrivals will not be admitted after 11:30AM
  • Pre-registered attendees will receive an immediate receipt/confirmation after submission
  • Please print this receipt/confirmation and bring it with you to receive your conference credentials
  • Photo ID (driver’s license or passport) will be required at check-in
  • All sales are final

Please mail your event-related questions to: or you can contact us via phone: 650-871-3257.

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!

In Collaboration with: